Andrew Raymon Morton Bradbury (Andrew R M Bradbury)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Venues

mAbs

PloS one

Nature communications

Nature biotechnology

Specifica

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Specifica Jun 01 2016

United States

Chief Scientific Officer

Los Alamos National Laboratory Jul 26 1999 - May 31 2017

United States

Scientist 5 :: B division

Scuola Internazionale Superiore di Studi Avanzati

Italy

Assistant Professor :: Biophysics Department

CNR Istituto di Neurobiologia

Italy

Postdoctoral Fellow

MRC Laboratory of Molecular Biology

United Kingdom

PhD student and Postdoctoral Fellow

Publications

Fortunato Ferrara, Adeline M Fanni, Andre A R Teixeira, Esteban Molina, Camila Leal-Lopes, Ashley DeAguero, Sara D'Angelo, Michael Frank Erasmus, Laura P Spector, Luis Antonio Rodriguez Carnero, Jianquan Li, Thomas J Pohl, Nikolai Suslov, Klervi Desrumeaux, Conor McMahon, Sagar V Kathuria, Andrew Raymon Morton Bradbury
A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability. mAbs 16 (1) (2024)
Fortunato Ferrara, Adeline M Fanni, Andre A R Teixeira, Esteban Molina, Camila Leal-Lopes, Ashley DeAguero, Sara D'Angelo, Michael Frank Erasmus, Laura P Spector, Luis Antonio Rodriguez Carnero, Jianquan Li, Thomas J Pohl, Nikolai Suslov, Klervi Desrumeaux, Conor McMahon, Sagar V Kathuria, Andrew Raymon Morton Bradbury
A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability. mAbs 16 (1) (2024)
Fortunato Ferrara, Adeline M Fanni, Andre A R Teixeira, Esteban Molina, Camila Leal-Lopes, Ashley DeAguero, Sara D'Angelo, Michael Frank Erasmus, Laura P Spector, Luis Antonio Rodriguez Carnero, Jianquan Li, Thomas J Pohl, Nikolai Suslov, Klervi Desrumeaux, Conor McMahon, Sagar V Kathuria, Andrew Raymon Morton Bradbury
A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability. mAbs 16 (1) (2024)
Nileena Velappan, Fortunato Ferrara, Sara D'Angelo, Devin Close, Leslie Naranjo, Madeline R Bolding, Sarah C Mozden, Camille B Troup, Donna K McCullough, Analyssa Gomez, Marijo Kedge, Andrew Raymon Morton Bradbury
Direct selection of functional fluorescent-protein antibody fusions by yeast display. PloS one 18 (2) (2023)
Nileena Velappan, Fortunato Ferrara, Sara D'Angelo, Devin Close, Leslie Naranjo, Madeline R Bolding, Sarah C Mozden, Camille B Troup, Donna K McCullough, Analyssa Gomez, Marijo Kedge, Andrew Raymon Morton Bradbury
Direct selection of functional fluorescent-protein antibody fusions by yeast display. PloS one 18 (2) (2023)
Nileena Velappan, Fortunato Ferrara, Sara D'Angelo, Devin Close, Leslie Naranjo, Madeline R Bolding, Sarah C Mozden, Camille B Troup, Donna K McCullough, Analyssa Gomez, Marijo Kedge, Andrew Raymon Morton Bradbury
Direct selection of functional fluorescent-protein antibody fusions by yeast display. PloS one 18 (2) (2023)
Fortunato Ferrara, M Frank Erasmus, Sara D'Angelo, Camila Leal-Lopes, André A Teixeira, Alok Choudhary, William Honnen, David Calianese, Deli Huang, Linghan Peng, James E Voss, David Nemazee, Dennis R Burton, Abraham Pinter, Andrew Raymon Morton Bradbury
A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies. Nature communications 13 (1) (2022)
Andre A R Teixeira, Sara D'Angelo, Michael Frank Erasmus, Camila Leal-Lopes, Fortunato Ferrara, Laura P Spector, Leslie Naranjo, Esteban Molina, Tamara Max, Ashley DeAguero, Katherine Perea, Shaun Stewart, Rebecca A Buonpane, Horacio G Nastri, Andrew Raymon Morton Bradbury
Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs. mAbs 14 (1) (2022)
Andrew Raymon Morton Bradbury, Stefan Dübel, Achim Knappik, Andreas Plückthun
Animal- versus in vitro-derived antibodies: avoiding the extremes. mAbs 13 (1) (2022)
Andre A R Teixeira, Michael Frank Erasmus, Sara D'Angelo, Leslie Naranjo, Fortunato Ferrara, Camila Leal-Lopes, Fortunato Ferrara, Cecile Galmiche, Aleardo Morelli, Anthony Scott-Tucker, Andrew Raymon Morton Bradbury
Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries. mAbs 13 (1) (2022)
Fortunato Ferrara, Sara D'Angelo, Michael Frank Erasmus, Andre A R Teixeira, Camila Leal-Lopes, Laura P Spector, Thomas J Pohl, Adeline M Fanni, Simon Cocklin, Andrew Raymon Morton Bradbury
Pandemic's silver lining. mAbs 14 (1) (2022)
Fortunato Ferrara, M Frank Erasmus, Sara D'Angelo, Camila Leal-Lopes, André A Teixeira, Alok Choudhary, William Honnen, David Calianese, Deli Huang, Linghan Peng, James E Voss, David Nemazee, Dennis R Burton, Abraham Pinter, Andrew Raymon Morton Bradbury
Author Correction: A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies. Nature communications 13 (1) (2022)
Nileena Velappan, Sofiya Micheva-Viteva, Samantha H Adikari, Geoffrey S Waldo, Antonietta M Lillo, Andrew Raymon Morton Bradbury
Selection and verification of antibodies against the cytoplasmic domain of M2 of influenza, a transmembrane protein. mAbs 12 (1) (2021)
Michael Frank Erasmus, Sara D'Angelo, Fortunato Ferrara, Leslie Naranjo, André A Teixeira, Rebecca Buonpane, Shaun M Stewart, Horacio G Nastri, Andrew Raymon Morton Bradbury
A single donor is sufficient to produce a highly functional in vitro antibody library. Communications biology 4 (1) (2021)
Jan L A Voskuil, Anita E Bandrowski, C Glenn Begley, Andrew Raymon Morton Bradbury, Andrew D Chalmers, Aldrin V Gomes, Travis Hardcastle, Fridtjof Lund-Johansen, Andreas Plückthun, Giovanna Roncador, Alejandra Solache, Michael J Taussig, James S Trimmer, Cecilia Williams, Simon L Goodman
The Antibody Society's antibody validation webinar series. mAbs 12 (1) (2021)
Alison Gray, Andrew Raymon Morton Bradbury, Achim Knappik, Andreas Plückthun, Carl A K Borrebaeck, Stefan Dübel
Animal-free alternatives and the antibody iceberg. Nature biotechnology 38 (11) (2020)
Antonietta Maria Lillo, Nileena Velappan, Julia M Kelliher, Austin J Watt, Samuel P Merriman, Grace Vuyisich, Laura M Lilley, Kent E Coombs, Tara Mastren, Munehiro Teshima, Benjamin W Stein, Gregory L Wagner, Srinivas Iyer, Andrew Raymon Morton Bradbury, Jennifer Foster Harris, Armand E K Dichosa, Stosh A Kozimor
Development of Anti-Yersinia pestis Human Antibodies with Features Required for Diagnostic and Therapeutic Applications. ImmunoTargets and therapy 9 (2020)

Andrew Raymon Morton Bradbury.css-eqlu8i{font-size:small;padding-left:4px;} (Andrew R M Bradbury)

Publication Activity (10 Years)

Top Topics

Top Venues

Andrew Raymon Morton Bradbury (Andrew R M Bradbury)